Article
Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations.
The Tohoku journal of experimental medicine - 1 Jun 2013
Kato Kaneko Mika, Ogasawara Satoshi, Kato Yukinari
Abstract excerpt
Mutations of isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) have been reported in gliomas, cartilaginous tumors, and acute myeloid leukemias. IDH mutations are specific to a single codon in the conserved and functionally important arginine 132 residue (R132) of IDH1 or arginine 172 residue (R172) of IDH2 in gliomas. Although IDH1 and IDH2 catalyze the oxidative carboxylation of isocitrate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
